1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP
  1. mopsie
    Pot Pill Going Back On The Market After 17 Years
    WASHINGTON Seventeen years after it was withdrawn from U.S. markets, a synthetic version of the active ingredient in marijuana is going back on sale as a prescription treatment for the vomiting and nausea that often accompanies chemotherapy, its California-based manufacturer said Tuesday.

    Valeant Pharmaceuticals International hopes to begin selling Cesamet in the next two to three weeks, company president Wes Wheeler said.

    The Costa Mesa company received Food and Drug Administration approval Monday to resume sales of the drug, which it bought from Eli Lilly and Co. in 2004. Valeant currently sells the drug, also called nabilone, in Canada.

    Lilly originally received FDA approval for nabilone in 1985 but withdrew it from the market in 1989, Wheeler said. Valeant, since purchasing the drug, has revised its label and updated its manufacturing process, he added.

    The drug will compete with Marinol, made by Belgium-based Solvay SA. Marinol, another synthetic version of tetrahydrocannabinol, the active ingredient in marijuana that's more commonly known as THC. It also received FDA approval in 1985.

    Synthetic THC acts on the brain like the THC in smoked marijuana, but eliminates having to inhale the otherwise harmful smoke contained in the illegal drug, Valeant said.

    Cesamet is a Schedule II drug, meaning it has a high potential for abuse. The 1-milligram tablets are meant to be taken twice daily before cancer patients undergo chemotherapy and up to 48 hours following treatment. Side effects include euphoria, drowsiness, vertigo and dry mouth.

    The FDA last month said it does not support the use of marijuana for medical purposes.



    source mapt :)

Comments

  1. mopsie
    WASHINGTON -- Seventeen years after it was withdrawn from U.S. markets, a synthetic version of the active ingredient in marijuana is going back on sale as a prescription treatment for the vomiting and nausea that often accompanies chemotherapy, its manufacturer said Tuesday.

    Valeant Pharmaceuticals International hopes to begin selling Cesamet in the next two to three weeks, company president Wes Wheeler said.

    The Costa Mesa, Calif. company received Food and Drug Administration approval Monday to resume sales of the drug, which it bought from Eli Lilly and Co. in 2004. Lilly originally received FDA approval for nabilone in 1985 but withdrew it from the market in 1989 for commercial reasons, Wheeler said Marinol, another synthetic version of tetrahydrocannabinol, the active ingredient in marijuana that's more commonly known as THC, is made by Belgium-based Solvay SA. It also received FDA approval in 1985.

    Cesamet is a Schedule II drug, meaning it has a high potential for abuse. The FDA last month said it does not support the use of marijuana for medical purposes.

    Source: Long Beach Press-Telegram (CA)
To make a comment simply sign up and become a member!